Professor Jesus Perez![]() University positionAssociate Lecturer DepartmentsHome pagehttp://www.psychiatry.cam.ac.uk Research ThemesInterestsMy research activity is mainly focused on early detection and intervention in psychosis. I am particularly interested in the epidemiology and psychopathology of people at high-risk of developing psychosis, with psychotic experiences and with first-episode psychosis. This includes clinical antecedents, neurobiological and sociodemographic characteristics. I am also keen in understanding the factors associated with diagnostic stability of first-episode psychotic disorders. As applied health researcher, an important part of my research activity is dedicated to service development within the NHS. I am the Lead Consultant Psychiatrist of the multi-award winning CAMEO Early Intervention in Psychosis Services; Lead Clinical Director of the National Institute for Health Research (NIHR) Clinical Research Network (CRN) East of England; Mental Health Theme Lead for the NIHR Applied Research Collaboration (ARC) East of England; and Honorary Professor at the University of East Anglia (UEA). Research Focus
EquipmentCross-sectional and cohort studies Neuropsychological testing Randomised control trials CollaboratorsNo collaborators listed Associated News Items
Publications2022Burn AM, Ford TJ, Stochl J, Jones PB, Perez J, Anderson JK (2022), “Developing a Web-Based App to Assess Mental Health Difficulties in Secondary School Pupils: Qualitative User-Centered Design Study” JMIR Form Res 10;6(1):e30565 Efstathopoulou L, Jagger G, Mackenzie J, Faulkner K, Barker-Barrett T, Cameron R, Wagner AP, Perez J (2022), “The Peterborough Exemplar: a protocol to evaluate the impact and implementation of a new patient-centred, system-wide community mental healthcare model in England” Health Res Policy Syst 5;20(1):16 Stochl J, Jones H, Soneson E, Wagner AP, Khandaker GM, Zammit S, Heron J, Hammerton G, Bullmore ET, Dolan R, Fonagy P, Goodyer IM, Perez J, Jones PB (2022), “Stratification of adolescents across mental phenomena emphasizes the importance of transdiagnostic distress: a replication in two general population cohorts.” Eur Child Adolesc Psychiatry. 2021Allen P, Hird EJ, Orlov N, Modinos G, Bossong M, Antoniades M, Sampson C, Azis M, Howes O, Stone J, Perez J, Broome M, Grace AA, McGuire P (2021), “Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function” Transl Psychiatry Nov 30;11(1):607. Cate Treise, Jesus Perez (2021), “The Role of Dissociative Compartmentalization in Difficult-to-Treat Psychotic Phenomena” Front Psychol April 9 Davies C, Appiah-Kusi E, Wilson R, Blest-Hopley G, Bossong MG, Valmaggia L, Brammer M, Perez J, Allen P, Murray RM, McGuire P, Bhattacharyya S. (2021), “Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report.” Eur Arch Psychiatry Clin Neurosci. Sep 4 Jan Stochl, Tamsin Ford, Jesus Perez, Peter B Jones (2021), “Modernising measurement in psychiatry: item banks and computerised adaptive testing” Lancet Psychiatry February 17 Kershenbaum A, Zandi MS, Perez J (2021), “Catatonia with glycine receptor antibodies: Heads up?” Schizophr Res 235:7-8. Modinos G, Richter A, Egerton A, Bonoldi I, Azis M, Antoniades M, Bossong M, Crossley N, Perez J, Stone JM, Veronese M, Zelaya F, Grace AA, Howes OD, Allen P, McGuire P (2021), “Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes” Neuropsychopharmacology May 3 Perry BI, Osimo EF, Upthegrove R, Mallikarjun PK, Yorke J, Stochl J, Perez J, Zammit S, Howes O, Jones PB, Khandaker GM (2021), “Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis” Lancet Psychiatry June 1 Stochl J, Soneson E, Stuart F, Fritz J, Walsh AEL, Croudace T, Hodgekins J, Patel U, Russo DA, Knight C, Jones PB, Perez J (2021), “Determinants of patient-reported outcome trajectories and symptomatic recovery in Improving Access to Psychological Therapies (IAPT) services” Psychol Med March 8 Treise C, Simmons C, Marshall N, Painter M, Perez J (2021), “Autism Spectrum Disorder in Early Intervention in Psychosis Services: Implementation and Findings of a 3-step Screening and Diagnostic Protocol” J Psychiatr Pract Jan 21;27(1):23-32. 2020Knight C, Russo D, Stochl J, Croudace T, Fowler D, Grey N, Reeve N, Jones PB, Perez J (2020), “Prevalence of and recovery from common mental disorder including psychotic experiences in the UK Primary Care Improving Access to Psychological Therapies (IAPT) Programme.” J Affect Disord May 3;272:84-90. Cathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, Grace Blest-Hopley, Michael Brammer, Jesus Perez, Robin M Murray, Paul Allen, Matthijs G Bossong, Philip McGuire, Sagnik Bhattacharyya (2020), “A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis” Transl Psychiatry Sep 13;10(1):311. Cathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, Michael Brammer, Jesus Perez, Robin Murray, Paul Allen, Matthijs Bossong, Philip McGuire, Sagnik Bhattacharyya (2020), “Effects of cannabidiol on emotion processing in psychosis risk: An FMRI Investigation” Schizophr Bull May; 46(Suppl 1): S286. Emanuele F Osimo, Benjamin I Perry, Rudolf N Cardinal, Mary-Ellen Lynall, Jonathan Lewis, Aarti Kudchadkar, Graham Murray, Jesus Perez, Peter B Jones, Golam M Khandaker (2020), “Inflammatory and Cardiometabolic Markers at Presentation with First Episode Psychosis and Long-term Clinical Outcomes: a longitudinal study using electronic health records” Brain Behav Immun Sep 17 Gifford G, Crossley N, Morgan S, Kempton MJ, Dazzan P, Modinos G, Azis M, Samson C, Bonoldi I, Quinn B, Smart SE, Antoniades M, Bossong MG, Broome MR, Perez J, Howes OD, Stone JM, Allen P, Grace AA, McGuire P (2020), “Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis. ” Hum Brain Mapp Oct 13 Jesus Perez, Clare Knight, Debra A Russo, Jan Stochl, Peter B Jones (2020), “Prevalence of and recovery from common mental disorders including psychotic experiences” Schizophr Bull May; 46(Suppl 1): S8. Ka-Young Ban, David PJ Osborn, Yasir Hameed, Santvana Pandey, Jesus Perez, Peter B Jones, James B Kirkbride (2020), “Personality Disorder in an Early Intervention Psychosis Cohort: Findings From the Social Epidemiology of Psychoses in East Anglia (SEPEA) Study” PLoS One Jun 5;15(6):e0234047. Knight C, Russo D, Stochl J, Jones PB, Perez J. (2020), “More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services - effect on prevalence and recovery: casting the net wider.” BJPsych Open Nov 6;6(6):e136. Modinos G, Allen P, Zugman A, Dima D, Azis M, Samson C, Bonoldi I, Quinn B, Gifford GWG, Smart SE, Antoniades M, Bossong MG, Broome MR, Perez J, Howes OD, Stone JM, Grace AA, McGuire P. (2020), “Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.” Schizophr Bull Apr 10;46(3):670-679. Soneson E, Perez J, Jones PB (2020), “Principles of Risk, Screening and Prevention in Psychiatry. In: Risk Factors for Psychosis: Paradigms, Mechanisms, and Prevention. Eds Thompson AD and Broome MR” Academic Press, Elsevier, London pp 11-43 Soneson E, Russo D, Stochl J, Heslin M, Galante J, Knight C, Grey N, Hodgekins J, French P, Fowler D, Lafortune L, Byford S, Jones PB, Perez J (2020), “Psychological interventions for people with psychotic experiences: A systematic review and meta-analysis of controlled and uncontrolled effectiveness and economic studies. ” Aust N Z J Psychiatry May 28 Spaul SW, Hudson R, Harvey C, Macdonald H, Perez J (2020), “Exclusion criterion: learning disability” Lancet Feb 15;395(10223):e29 Stochl J, Fried EI, Fritz J, Croudace TJ, Russo DA, Knight C, Jones PB, Perez J (2020), “On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7” Assessment Dec 3 Woods SW, Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers AR 3rd, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, Mittal VA, Schiffman J, Ellman LM, Strauss GP, Mamah D, Choi J, Pearlson GD, Shah JL, Fusar-Poli P, Arango C, Perez J, Koutsouleris N, Wang J, Kwon JS, Walsh BC, McGlashan TH, Hyman SE, Gur RE, Cannon TD, Kane JM, Anticevic A (2020), “Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.” Schizophr Res May 10 2019Bonoldi I, Allen P, Madeira L, Tognin S, Bossong MG, Azis M, Samson C, Quinn B, Calem M, Valmaggia L, Modinos G, Stone J, Perez J, Howes O, Politi P, Kempton MJ, Fusar-Poli P, McGuire P (2019), “Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for Psychosis” Front Psychiatry May 10;10:254 Dobler VB, Neufeld SAS, Fletcher PF, Perez J, Subramaniam N, Teufel C, Goodyer IM (2019), “Disaggregating physiological components of cortisol output: A novel approach to cortisol analysis in a clinical sample - A proof--of-principle study” Neurobiol Stress Mar 7;10:100153 Gemma Modinos, Paul Allen, Andre Zugman, Danai Dima, Matilda Azis, Carly Samson, Ilaria Bonoldi, Beverly Quinn, George W G Gifford, Sophie E Smart, Mathilde Antoniades, Matthijs G Bossong, Matthew R Broome, Jesus Perez, Oliver D Howes, James M Stone, Anthony A Grace, Philip McGuire (2019), “Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome” Schizophr Bull Sep 18 Howes OD, Bonoldi I, McCutcheon RA, Azis M, Antoniades M, Bossong M, Modinos G, Perez J, Stone JM, Santangelo B, Veronese M, Grace A, Allen P, McGuire PK (2019), “Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study” Neuropsychopharmacology Oct 16 Jagger G, de la Fuente-Tomas L, Stochl J, Allan SM, Clay F, Kenedler L, Treise C, Perez J (2019), “Early Intervention in Psychosis Treatment Components Utilization in Patients Aged Over 35” Community Ment Health J Sep 28 Knight C, Stochl J, Soneson E, Russo DA, Jones PB, Perez J (2019), “Revisiting CAPE-P15 cut-off values to increase sensitivity for detecting psychotic experiences in primary care” Schizophr Res Dec 5 Modinos G, Allen P, Zugman A, Danai D, Azis M, Samson C, Bonoldi I, Quinn B, Gifford G, Smart S, Antoniades M, Bossong MJ, Broome MR, Perez J, Howes OD, Stone JM, Grace A, McGuire P (2019), “Altered hyppocampal-striatal-midbrain function in subjects at clinical high risk of psychosis” Schizophr Bull Montejo AL, Calama J, Rico-Villademoros F, Montejo L, González García N, Pérez J; SALSEX Working Study Group (2019), “A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study” Arch Sex Behav Feb 21 Osimo EF, Goujon MJ, Perez J, Murray GK. (2019), “Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?” BMJ Case Rep Mar 31;12(3). pii: e228573. Perez J, Jones PB (2019), “Breaking the web: life beyond the at-risk mental state for psychosis” Psychol Med Sep 30:1-6 Scoriels L, Zimbron J, Garcia-León N, Coll-Negre M, Giro M, Perez J, Jones PB, Fernandez-Egea E (2019), “Cross-sectional study of diet patterns in early and chronic schizophrenia” Schizophr Res April 11 Sevilla-Llewellyn-Jones J, Perez J, Cano-Domínguez P, de-Luis-Matilla A, Espina-Eizaguirre A, Reneses B, Ochoa S (2019), “Clinical personality traits and parental bonding in patients with recent onset of psychosis” Schizophr Res Aug 6 Soneson E, Russo D, Knight C, Lafortune L, Heslin M, Stochl J, Georgiadis A, Galante J, Duschinsky R, Grey N, Gonzalez-Blanco L, Couche J, Griffiths M, Murray H, Reeve N, Hodgekins J, French P, Fowler D, Byford S, Dixon-Woods M, Jones PB, Perez J (2019), “Psychological interventions for people with psychotic experiences: protocol for a systematic review and meta-analysis” Syst Rev May 23;8(1):124 Soneson E, Russo D, Knight C, Lafortune L, Heslin M, Stochl J, Georgiadis A, Galante J, Duschinsky R, Grey N, Gonzalez-Blanco L, Couche J, Griffiths M, Murray H, Reeve N, Hodgekins J, French P, Fowler D, Byford S, Dixon-Woods M, Jones PB, Perez J (2019), “Psychological interventions for people with psychotic experiences: protocol for a systematic review and meta-analysis” Syst Rev May 23;8(1):124 Treise C, Brown RJ, Perez J (2019), “Towards a Multi-Level Phenomenology of Delusional Disorder: The Dissociative Thought-Script” Psychopathology May 14;52(1):50-58 Turrion MC, Perez J, Bernardo M, Fernandez-Egea E (2019), “Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice” Rev Psiquiatr Salud Ment May 21 Wilson R, Bossong MG, Appiah-Kusi E, Petros N, Brammer M, Perez J, Allen P, McGuire P, Bhattacharyya S (2019), “Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis” Transl Psychiatry Aug 22;9(1):203 2018Allan S, Cella M, Wykes T, Perez J (2018), “Cognitive remediation therapy for psychotic major depressive disorder” Prim Care Companion CNS Disord June 14 Bhattacharyya S, Wilson R, Appiah-Kusi E, O'Neill A, Brammer M, Perez J, Murray R, Allen P, Bossong MG, McGuire P (2018), “Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial” JAMA Psychiatry Aug 29 Bossong MG, Antoniades M, Azis M, Samson C, Quinn B, Bonoldi I, Modinos G, Perez J, Howes OD, Stone JM, Allen P, McGuire P (2018), “Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis” JAMA Psychiatry Nov 14 Clay F, Allan S, Lai S, Laverty S, Jagger G, Treise C, Perez J (2018), “The over-35s: early intervention in psychosis services entering uncharted territory” BJPsych Bull May 24:1-4 Georgiadis A, Duschinsky R, Perez J, Jones PB, Russo D, Knight C, Soneson E, Dixon-Woods M (2018), “Coproducing healthcare service improvement for people with common mental health disorders including psychotic experiences: a study protocol of a multiperspective qualitative study” BMJ Open Nov 8;8(11):e026064 Modinos G, ?im?ek F, Azis M, Bossong M, Bonoldi I, Samson C, Quinn B, Perez J, Broome MR, Zelaya F, Lythgoe DJ, Howes OD, Stone JM, Grace AA, Allen P, McGuire P (2018), “Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis” Neuropsychopharmacology Jan 30 Perez J, Jin H, Russo D, Stochl J, Painter M, Byford S, Jones PB (2018), “Improving the detection of individual at risk of developing psychosis in primary mental health care” Schizophr Bull April Sevilla-Llewellyn-Jones J, Camino G, Russo DA, Painter M, Montejo AL, Ochoa S, Jones PB, Perez J (2018), “Clinically significant personality traits in individuals at high risk of developing psychosis” Psychiatry Res Jan 12;261:498-503 Solmi F, Mohammadi, Perez J, Hameed Y, Jones PB, Kirkbride J (2018), “Predictors of disengagement from Early Intervention in Psychosis services” Br J Psychiatry June Wykes T, Joyce E, Velikonja T, Watson A, Aarons G, Birchwood M, Cella M, Dopson S, Fowler D, Greenwood K, Johnson S, McCrone P, Perez J, Pickles A, Reeder C, Rose D, Singh S, Stringer D, Taylor M, Taylor R, Upthegrove R (2018), “The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial” Trials Mar 15;19(1):183 2017Allen P, Azis M, Modinos G, Bossong MG, Bonoldi I, Samson C, Quinn B, Kempton MJ, Howes OD, Stone JM, Calem M, Perez J, Bhattacharayya S, Broome MR, Grace AA, Zelaya F, McGuire P (2017), “Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort.” Schizophr Bull Dec 17 Bukenaite A, Stochl J, Mossaheb N, Schäfer MR, Klier CM, Becker J, Schloegelhofer M, Papageorgiou K, Montejo AL, Russo DA, Jones PB, Amminger GP, Perez J (2017), “Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values” Schizophr Res Feb 26 Fontalba-Navas A, Lucas-Borja ME, Gil-Aguilar V, Arrebola JP, Pena-Andreu JM, Perez J (2017), “Incidence and risk factors for post-traumatic stress disorder in a population affected by a severe flood” Public Health Mar;144:96-102 Kirkbride JB, Hameed Y, Ioannidis K, Ankireddypalli G, Crane CM, Nasir M, Kabacs N, Metastasio A, Jenkins O, Espandian A, Spyridi S, Ralevic D, Siddabattuni S, Walden B, Adeoye A, Perez J, Jones PB (2017), “Ethnic Minority Status, Age-at-Immigration and Psychosis Risk in Rural Environments: Evidence From the SEPEA Study” Schizophr Bull May 17 Kirkbride JB, Hameed Y, Wright L, Russell K, Knight C, Perez J, Jones PB (2017), “Waiting time variation in Early Intervention Psychosis services: longitudinal evidence from the SEPEA naturalistic cohort study” Soc Psychiatry Psychiatr Epidemiol Feb 18 Modinos G, Simsek F, Horder J, Bossong M, Bonoldi I, Azis M, Perez J, Broome M, Lythgoe DJ, Stone JM, Howes OD, Murphy DG, Grace AA, Allen P, McGuire P (2017), “Cortical GABA In Subjects At Ultra-High Risk Of Psychosis: Relationship To Negative Prodromal Symptoms” Int J Neuropsychopharmacol Aug 19 Montejo ÁL, Arango C, Bernardo M, Carrasco JL, Crespo-Facorro B, Cruz JJ, Del Pino-Montes J, García-Escudero MA, García-Rizo C, González-Pinto A, Hernández AI, Martín-Carrasco M, Mayoral-Cleries F, Mayoral-van Son J, Mories MT, Pachiarotti I, Pérez J, Ros S, Vieta E (2017), “Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics” Front Neuroendocrinol Feb 21 Perez J, Russo DA, Stochl J, Clarke J, Martin Z, Jassi C, French P, Fowler D, Jones PB (2017), “Common mental disorder including psychotic experiences: Trailblazing a new recovery pathway within the Improving Access to Psychological Therapies programme in England” Early Interv Psychiatry May 16 Richardson L, Hameed Y, Perez J, Jones PB, Kirkbride JB (2017), “Association of Environment With the Risk of Developing Psychotic Disorders in Rural Populations: Findings from the Social Epidemiology of Psychoses in East Anglia Study” JAMA Psychiatry Nov 29 Russo DA, Stochl J, Hodgekins J, Iglesias-González M, Chipps P, Painter M, Jones PB, Perez J (2017), “Attachment styles and clinical correlates in people at ultra high risk for psychosis” Br J Psychol April 24 2016Fusar-Poli P, Cappucciati M, Rutigliano G, Lee TY, Beverly Q, Bonoldi I, Lelli J, Kaar SJ, Gago E, Rocchetti M, Patel R, Bhavsar V, Tognin S, Badger S, Calem M, Lim K, Kwon JS, Perez J, McGuire P (2016), “Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS” Psychiatry Journal Kirkbride JB, Hameed Y, Ankireddypalli G, Ioannidis K, Crane CM, Nasir M, Kabacs N, Metastasio A, Jenkins O, Espandian A, Spyridi S, Ralevic D, Siddabattuni S, Walden B, Adeoye A, Perez J, Jones PB (2016), “The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study” Am J Psychiatry Oct 24 Kirkbride JB, Perez J, Jones PB (2016), “Neighbourhood communalities and ultra-high risk psychosis: An emergent literature” Schizophr Res Jun 22 Lennox BR, Palmer-Cooper EC, Pollak T, Hainsworth J, Marks J, Jacobson L, Lang B, Fox H, Ferry B, Scoriels L, Crowley H, Jones PB, Harrison PJ, Vincent A; PPiP study team. (2016), “Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study” Lancet Psychiatry Dec 6 Madeira L, Bonoldi I, Rocchetti M, Brandizzi M, Samson C, Azis M, Queen B, Bossong M, Allen P, Perez J, Howes OD, McGuire P, Fusar-Poli P (2016), “Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis” Psychiatry Res Apr 30;238:270-6. Madeira L, Bonoldi I, Rocchetti M, Samson C, Azis M, Queen B, Bossong M, Perez J, Stone J, Allen P, Howes OD, McGuire P, Raballo A, Fusar-Poli P, Ballerini M, Stanghellini G (2016), “An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications.” Compr Psychiatry Apr;66:39-45 Perez J, Jones PB (2016), “Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution - Authors' reply” Lancet Psychiatry Jan;3(1):18-19 Perez J, Russo DA, Stochl J, Shelley GF, Crane CM, Painter M, Kirkbride JB, Croudace TJ, Jones PB (2016), “Understanding causes of and developing effective interventions for schizophrenia and other psychoses.” Southampton (UK): NIHR Journals Library Tohen M, Khalsa HK, Salvatore P, Zarate CA Jr, Strakowski SM, Perez J, Baldessarini RJ (2016), “The McLean-Harvard First-Episode Project: early course in 114 cases of first-episode nonaffective psychoses” J Clin Psychiatry May 10 2015Baldessarini RJ, Perez J, Salvatore P, Trede K, Maggini C (2015), “History of Bipolar Manic-Depressive Disorder.” In A Yildiz, P Ruiz, C Nemeroff (Eds.), The Bipolar Book: History, Neurobiology and Treatment (pp 3-19). New York: Oxford University Press Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, Perez J, Keri S, Amminger P, Metzler S, Kawohl W, Rössler W, Lee J, Labad J, Ziermans T, An SK, Liu CC, Woodberry KA, Braham A, Corcoran C, McGorry P, Yung AR, McGuire PK (2015), “Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification” JAMA Psychiatry Dec 30 Mishara A, Bonoldi I, Allen P, Rutigliano G, Perez J, Fusar-Poli P, McGuire P (2015), “Neurobiological Models of Self-Disorders in Early Schizophrenia.” Schizophr Bull Sep 18 Morcillo C, Stochl J, Russo DA, Zambrana A, Ratnayake N, Jones PB, Perez J (2015), “First-Rank Symptoms and Premorbid Adjustment in Young Individuals at Increased Risk of Developing Psychosis.” Psychopathology Details Pérez J (2015), “Women of the Surrey County Lunatic Asylum: first photographic portraits of mental illness (1852).” Arch Womens Ment Health Sep 19 Perez J, Jin H, Russo DA, Stochl J, Painter M, Shelley G, Jackson E, Crane C, Graffy JP, Croudace TJ, Byford S, Jones PB (2015), “Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial.” Lancet Psychiatry Details Russo DA, Stochl J, Painter M, Shelley GF, Jones PB, Perez J (2015), “Use of the Theory of Planned Behaviour to assess factors influencing the identification of students at clinical high-risk for psychosis in 16+ Education.” BMC Health Serv Sep 23;15(1):411 Sahakian BJ, Bruhl AB, Cook J, Killikelly C, Savulich G, Piercy T, Hafizi S, Perez J, Fernandez-Egea E, Suckling J, Jones PB (2015), “The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.” Philos Trans R Soc Lond B Biol Sci 370(1677) Details Stochl J, Jones PB, Perez J, Khandaker GM, Böhnke JR, Croudace TJ (2015), “Effects of ignoring clustered data structure in confirmatory factor analysis of ordered polytomous items: a simulation study based on PANSS.” Int J Methods Psychiatr Res Details Teufel C, Subramaniam N, Dobler V, Perez J, Finnemann J, Mehta PR, Goodyer IM, Fletcher PC (2015), “Shift toward prior knowledge confers a perceptual advantage in early psychosis and psychosis-prone healthy individuals.” Proc Natl Acad Sci U S A Oct 12 2014Kirkbride JB, Stochl J, Zimbrón J, Crane CM, Metastasio A, Aguilar E, Webster R, Theegala S, Kabacs N, Jones PB, Perez J (2014), “Social and spatial heterogeneity in psychosis proneness in a multilevel case-prodrome-control study.” Acta Psychiatr Scand Details Russo DA, Stochl J, Painter M, Dobler V, Jackson E, Jones PB, Perez J (2014), “Trauma history characteristics associated with mental states at clinical high risk for psychosis.” Psychiatry Res Details Russo DA, Stochl J, Painter M, Jones PB, Perez J (2014), “Substance use in people at clinical high-risk for psychosis.” BMC Psychiatry 14(1):2 Details Stochl J, Jones PB, Plaistow J, Reininghaus U, Priebe S, Perez J, Croudace TJ (2014), “Multilevel ordinal factor analysis of the Positive and Negative Syndrome Scale (PANSS).” Int J Methods Psychiatr Res Details Stochl J, Khandaker GM, Lewis G, Perez J, Goodyer IM, Zammit S, Sullivan S, Croudace TJ, Jones PB (2014), “Mood, anxiety and psychotic phenomena measure a common psychopathological factor.” Psychol Med :1-11 Details 2013Hui C, Morcillo C, Russo DA, Stochl J, Shelley GF, Painter M, Jones PB, Perez J (2013), “Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis.” Schizophr Res Details Kirkbride JB, Jackson D, Perez J, Fowler D, Winton F, Coid JW, Murray RM, Jones PB (2013), “A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data.” BMJ Open 3(2) Details Perez J (2013), “Review: about one in five people with first-episode psychosis have a history of deliberate self-harm.” Evid Based Ment Health Details Perez J, Faedda GL, Baldessarini RJ (2013), “Electricity rendered useful for mental illness: tribute to Richard Lovett” Br J Psychiatry 203(4):241 Pérez J, Girón-Irueste F, Gurpegui M, Baldessarini RJ, de Leon J (2013), “The lions of granada maristan.” Am J Psychiatry 170(2):152-3 Details Perez J, Russo DA, Stochl J, Byford S, Zimbron J, Graffy JP, Painter M, Croudace TJ, Jones PB (2013), “Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial.” Trials 14(1):222 Details Salvatore P, Baldessarini RJ, Khalsa HM, Vázquez G, Perez J, Faedda GL, Amore M, Maggini C, Tohen M (2013), “Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients.” Acta Psychiatr Scand Details 2012Pérez J (2012), “"On paroxysmal anxiety" by Édouard Brissaud (1890).” J Clin Psychiatry 73(5):616 Details Pérez J (2012), “What if DSM 5 Attenuated Psychosis Syndrome Did Not Refer to Risk, but a forme fruste.” Psychopathology Details Perez J (2012), “[Influence of Religion in the Phenomenology of Anxiety: The Salvation of Mankind in post-Reformation Western Europe]” Rev Hist Psicol 33(2):61-80 Pérez J, Baldessarini RJ, Undurraga J, Sánchez-Moreno J (2012), “Origins of Psychiatric Hospitalization in Medieval Spain.” Psychiatr Q Details Stochl J, Croudace T, Perez J, Birchwood M, Lester H, Marshall M, Amos T, Sharma V, Fowler D, Jones PB, The National Eden Study Team (2012), “Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis.” Qual Life Res Details Zimbrón J, Ruiz de Azúa S, Khandaker GM, Gandamaneni PK, Crane CM, González-Pinto A, Stochl J, Jones PB, Pérez J (2012), “Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis.” Acta Psychiatr Scand Details 2011Agius M, Perez J (2011), “Do large studies of the use of antipsychotics help us choose the most effective treatments for schizophrenia?” CEPiP 1:69-73 Cheng F, Kirkbride JB, Lennox BR, Perez J, Masson K, Lawrence K, Hill K, Feeley L, Painter M, Murray GK, Gallagher O, Bullmore ET, Jones PB (2011), “Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.” Psychol Med 41(5):949-58 Details Kabacs N, Memon A, Obinwa T, Stochl J, Perez J (2011), “Lithium in drinking water and suicide rates across the East of England.” Br J Psychiatry 198(5):406-7 Details Pérez J, Baldessarini RJ, Cruz N, Salvatore P, Vieta E (2011), “Andrés Piquer-Arrufat (1711-1772): contributions of an eighteenth-century spanish physician to the concept of manic-depressive illness.” Harv Rev Psychiatry 19(2):68-77 Details Russo DA, Stochl J, Croudace TJ, Graffy JP, Youens J, Jones PB, Perez J (2011), “Use of the theory of planned behaviour to assess factors influencing the identification of individuals at ultra-high risk for psychosis in primary care.” Early Interv Psychiatry Details Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, Maggini C (2011), “McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.” J Clin Psychiatry 72(2):183-93 Details 2010Baldessarini RJ, Bolzani L, Cruz N, Jones PB, Lai M, Lepri B, Perez J, Salvatore P, Tohen M, Tondo L, Vieta E (2010), “Onset-age of bipolar disorders at six international sites.” J Affect Disord 121(1-2):143-6 Details Baldessarini RJ, Salvatore P, Khalsa HM, Gebre-Medhin P, Imaz H, González-Pinto A, Perez J, Cruz N, Maggini C, Tohen M (2010), “Morbidity in 303 first-episode bipolar I disorder patients.” Bipolar Disord 12(3):264-70 Details 2009Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, Maggini C (2009), “McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.” J Clin Psychiatry 70(4):458-66 Details 2007Montoya A, Gilaberte I, Costi M, Pérez Sánchez Toledo J, González Pinto A, Ma Haro J, Comes M, Vieta E (2007), “[Bipolar disorder in Spain: functional status and resource use on the basis of the Spanish sample of the observational, Pan European EMBLEM study].” Vertex 18(71):13-9 Details Montoya A, Pérez Sánchez Toledo J, Gilaberte I, González-Pinto A, Haro JM, Vieta E, Tohen M (2007), “Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study.” Actas Esp Psiquiatr 35(5):315-22 Details |